Terms: = Gastric cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Clinical Outcome
6 results:
1. Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer.
Hwang N; Yoon BK; Chun KH; Kim H; Lee Y; Kim JW; Jeon H; Kim TH; Kim MY; Fang S; Cheong JH; Kim JW
Exp Mol Med; 2023 Nov; 55(11):2461-2472. PubMed ID: 37919422
[TBL] [Abstract] [Full Text] [Related]
2. OCT4-mediated transcription confers oncogenic advantage for a subset of gastric tumors with poor clinical outcome.
Pandian J; Panneerpandian P; Sekar BT; Selvarasu K; Ganesan K
Funct Integr Genomics; 2022 Dec; 22(6):1345-1360. PubMed ID: 35987846
[TBL] [Abstract] [Full Text] [Related]
3. Inhibition or Reversal of the Epithelial-Mesenchymal Transition in gastric cancer: Pharmacological Approaches.
Kozak J; Forma A; Czeczelewski M; Kozyra P; Sitarz E; Radzikowska-Büchner E; Sitarz M; Baj J
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383973
[TBL] [Abstract] [Full Text] [Related]
4. The role of the obestatin/GPR39 system in human gastric adenocarcinomas.
Alén BO; Leal-López S; Alén MO; Viaño P; García-Castro V; Mosteiro CS; Beiras A; Casanueva FF; Gallego R; García-Caballero T; Camiña JP; Pazos Y
Oncotarget; 2016 Feb; 7(5):5957-71. PubMed ID: 26716511
[TBL] [Abstract] [Full Text] [Related]
5. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract] [Full Text] [Related]
6. Integrated microRNA network analyses identify a poor-prognosis subtype of gastric cancer characterized by the miR-200 family.
Song F; Yang D; Liu B; Guo Y; Zheng H; Li L; Wang T; Yu J; Zhao Y; Niu R; Liang H; Winkler H; Zhang W; Hao X; Chen K
Clin Cancer Res; 2014 Feb; 20(4):878-89. PubMed ID: 24352645
[TBL] [Abstract] [Full Text] [Related]
